|
|
|
|
Anti-GCG / Glucagon Antibody (aa21-50, CF) LS-C183887
Most Popular GCG / Glucagon Antibodies
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
|
|
Details
| Human GCG / Glucagon | |
| Rabbit | |
| Human (tested or 100% immunogen sequence identity) | |
| IgG Polyclonal | |
| Carboxyfluorescein | |
| Purified | |
| Unmodified |
Applications
| ELISA |
Specificity and Use
| GCG / Glucagon antibody was raised against synthetic peptide corresponding to aa21-50 of human Glicentin-related Polypeptide. | |
| aa21-50 | |
| Human Glicentin-related Polypeptide. | |
| The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. |
Packaging
| Liquid | |
| May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. Sensitive to light. | |
| For research use only. |
About GCG / Glucagon
P01275
NM_002054
NP_002045.1
GCG Antibody, GLP2 Antibody, Glucagon Antibody, Glucagon-like peptide 2 Antibody, GRPP Antibody, Glicentin-related polypeptide Antibody, GLP1 Antibody, Glucagon-like peptide 1 Antibody
Glucagon plays a key role in glucose metabolism and homeostasis. Regulates blood glucose by increasing gluconeogenesis and decreasing glycolysis. A counterregulatory hormone of insulin, raises plasma glucose levels in response to insulin-induced hypoglycemia. Plays an important role in initiating and maintaining hyperglycemic conditions in diabetes.GLP-1 is a potent stimulator of glucose-dependent insulin release.
Print This Page
Technical Help
Review This Product
Requested From:
Date Requested: 6/22/2017
Date Requested: 6/22/2017
